A detailed history of Dearborn Partners LLC transactions in Baxter International Inc stock. As of the latest transaction made, Dearborn Partners LLC holds 7,258 shares of BAX stock, worth $260,344. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,258
Previous 7,258 -0.0%
Holding current value
$260,344
Previous $310,000 21.94%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

SELL
$37.58 - $52.57 $6,012 - $8,411
-160 Reduced 2.16%
7,258 $294,000
Q4 2022

Feb 02, 2023

SELL
$49.7 - $57.71 $16,699 - $19,390
-336 Reduced 4.33%
7,418 $378,000
Q3 2022

Oct 25, 2022

BUY
$53.86 - $66.8 $2,100 - $2,605
39 Added 0.51%
7,754 $418,000
Q2 2022

Jul 20, 2022

SELL
$63.83 - $80.0 $20,744 - $26,000
-325 Reduced 4.04%
7,715 $496,000
Q1 2022

May 04, 2022

BUY
$76.85 - $89.45 $48,031 - $55,906
625 Added 8.43%
8,040 $623,000
Q4 2021

Jan 28, 2022

BUY
$74.57 - $87.19 $4,548 - $5,318
61 Added 0.83%
7,415 $637,000
Q2 2021

Jul 26, 2021

BUY
$80.5 - $88.01 $7,728 - $8,448
96 Added 1.32%
7,354 $592,000
Q1 2021

Apr 29, 2021

SELL
$76.38 - $86.03 $41,321 - $46,542
-541 Reduced 6.94%
7,258 $612,000
Q1 2019

May 01, 2019

SELL
$64.48 - $81.31 $19,344 - $24,393
-300 Reduced 3.7%
7,799 $634,000
Q4 2018

Feb 04, 2019

BUY
$61.45 - $77.8 $102,129 - $129,303
1,662 Added 25.82%
8,099 $533,000
Q3 2018

Oct 24, 2018

BUY
$70.71 - $77.75 $7,070 - $7,775
100 Added 1.58%
6,437 $496,000
Q1 2018

May 01, 2018

SELL
$62.56 - $72.26 $12,949 - $14,957
-207 Reduced 3.16%
6,337 $412,000
Q2 2017

Aug 09, 2017

BUY
N/A
6,544
6,544 $396,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $18.1B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Dearborn Partners LLC Portfolio

Follow Dearborn Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dearborn Partners LLC with notifications on news.